The Promise and Challenges of CRISPR Gene Therapy for Sickle Cell Disease
Snapshot CRISPR’s Potential as a Cure for Sickle Cell Disease The High Cost of Treatment and Accessibility Issues…
Day: January 9, 2024
8 posts
#37 – Far Reaching At-Home Patient Care: Dr. Marcy Carty’s Vision with MyLaurel
In this episode we discuss: Welcome back to Bringing Care Home! In this episode host Kathy McGuire is…
Ceretype Neuromedicine Secures Oversubscribed Seed Funding, Advancing fMRI Technology in Drug Discovery
Key Highlights Oversubscribed $2MM funding: Ceretype’s second seed funding round exceeds expectations, promising further advancements in functional MRI technology.…
Kiyatec Announces Leadership Transition: Eric Perreault Appointed New CEO
Key Highlights Eric Perreault promoted to CEO, succeeding co-founder Matt Gevaert, PhD. Focused on revolutionizing cancer care with KIYA-Predict™ and…
Marc Yoskowitz Takes Helm as CEO at Evozyne to Propel AI-Driven Drug Discovery
Key Highlights Marc Yoskowitz appointed as CEO of Evozyne, bringing extensive leadership from Tempus AI, Pfizer, and McKinsey.…
Twist Bioscience Appoints Adam Laponis as New Chief Financial Officer
Key Highlights Adam Laponis joins Twist Bioscience as the Chief Financial Officer, bringing extensive experience from small cap and…
Clarametyx Biosciences Secures $33M in Series A Funding to Propel Anti-Biofilm Technology
Key Highlights Clarametyx Biosciences Inc. secures $33 million in Series A funding, targeting persistent infections associated with biofilms. Funds…
Linkwell Health Appoints Jim Politte as Chief Growth Officer to Drive Enhanced Healthcare Engagement
Key Highlights Jim Politte appointed as Chief Growth Officer at Linkwell Health to expand the company’s delivery of high-performing…